BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 29681727)

  • 1. Time-Kill Kinetics of Rezafungin (CD101) in Vagina-Simulative Medium for Fluconazole-Susceptible and Fluconazole-Resistant
    Locke JB; Almaguer AL; Donatelli JL; Bartizal KF
    Infect Dis Obstet Gynecol; 2018; 2018():7040498. PubMed ID: 29681727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis.
    Boikov DA; Locke JB; James KD; Bartizal K; Sobel JD
    J Antimicrob Chemother; 2017 May; 72(5):1355-1358. PubMed ID: 28158577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rezafungin
    Helleberg M; Jørgensen KM; Hare RK; Datcu R; Chowdhary A; Arendrup MC
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro potency and fungicidal activity of CD101, a novel echinocandin, against recent clinical isolates of Candida spp.
    Hall D; Bonifas R; Stapert L; Thwaites M; Shinabarger DL; Pillar CM
    Diagn Microbiol Infect Dis; 2017 Nov; 89(3):205-211. PubMed ID: 28826987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of a Long-Acting Echinocandin, Rezafungin, and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates (SENTRY Program, 2016 to 2018).
    Pfaller MA; Carvalhaes C; Messer SA; Rhomberg PR; Castanheira M
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Rezafungin Provisional CLSI Clinical Breakpoints and Epidemiological Cutoff Values Tested against a Worldwide Collection of Contemporaneous Invasive Fungal Isolates (2019 to 2020).
    Carvalhaes CG; Klauer AL; Rhomberg PR; Pfaller MA; Castanheira M
    J Clin Microbiol; 2022 Apr; 60(4):e0244921. PubMed ID: 35249367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
    Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicentre determination of rezafungin (CD101) susceptibility of Candida species by the EUCAST method.
    Arendrup MC; Meletiadis J; Zaragoza O; Jørgensen KM; Marcos-Zambrano LJ; Kanioura L; Cuenca-Estrella M; Mouton JW; Guinea J
    Clin Microbiol Infect; 2018 Nov; 24(11):1200-1204. PubMed ID: 29505881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of rezafungin against common and rare Candida species and Saccharomyces cerevisiae.
    Tóth Z; Forgács L; Locke JB; Kardos G; Nagy F; Kovács R; Szekely A; Borman AM; Majoros L
    J Antimicrob Chemother; 2019 Dec; 74(12):3505-3510. PubMed ID: 31539426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EUCAST Reference Testing of Rezafungin Susceptibility and Impact of Choice of Plastic Plates.
    Arendrup MC; Jørgensen KM; Hare RK; Cuenca-Estrella M; Zaragoza O
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fungicidal efficacy of various honeys against fluconazole-resistant Candida species isolated from HIV
    Shokri H; Sharifzadeh A
    J Mycol Med; 2017 Jun; 27(2):159-165. PubMed ID: 28159362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced Antifungal Susceptibility of Vulvovaginal Candida Species at Normal Vaginal pH Levels: Clinical Implications.
    Spitzer M; Wiederhold NP
    J Low Genit Tract Dis; 2018 Apr; 22(2):152-158. PubMed ID: 29474241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fungicidal activity of fluconazole against Candida albicans in a synthetic vagina-simulative medium.
    Moosa MY; Sobel JD; Elhalis H; Du W; Akins RA
    Antimicrob Agents Chemother; 2004 Jan; 48(1):161-7. PubMed ID: 14693534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal susceptibility of Candida species isolated from patients with candidemia in southern Taiwan, 2007-2012: impact of new antifungal breakpoints.
    Chen YC; Kuo SF; Chen FJ; Lee CH
    Mycoses; 2017 Feb; 60(2):89-95. PubMed ID: 27621210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species.
    Pfaller MA; Rhomberg PR; Messer SA; Castanheira M
    Diagn Microbiol Infect Dis; 2015 Apr; 81(4):259-63. PubMed ID: 25600842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Identification and susceptibility against fluconazole and albaconazole of 100 yeasts' strains isolated from vaginal discharge].
    Arechavala AI; Bianchi MH; Robles AM; Santiso G; Negroni R
    Rev Iberoam Micol; 2007 Dec; 24(4):305-8. PubMed ID: 18095765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD101, a long-acting echinocandin, and comparator antifungal agents tested against a global collection of invasive fungal isolates in the SENTRY 2015 Antifungal Surveillance Program.
    Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
    Int J Antimicrob Agents; 2017 Sep; 50(3):352-358. PubMed ID: 28689871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.